Cachet Pharmaceutical Co., Ltd. (002462.SZ)
CNY 13.73
(-0.94%)
CNY 13.73
(-0.94%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 250.06 Million CNY | -46.6% |
| 2022 | 468.31 Million CNY | -22.19% |
| 2021 | 601.87 Million CNY | 1.86% |
| 2020 | 590.9 Million CNY | -10.44% |
| 2019 | 659.8 Million CNY | 101.38% |
| 2018 | 327.63 Million CNY | 24.27% |
| 2017 | 263.64 Million CNY | 18.17% |
| 2016 | 223.09 Million CNY | 28.98% |
| 2015 | 172.97 Million CNY | -24.15% |
| 2014 | 228.06 Million CNY | 75.2% |
| 2013 | 130.16 Million CNY | 99.62% |
| 2012 | 65.2 Million CNY | 2.4% |
| 2011 | 63.68 Million CNY | 31.19% |
| 2010 | 48.54 Million CNY | 14.44% |
| 2009 | 42.41 Million CNY | 2.57% |
| 2008 | 41.35 Million CNY | -77.35% |
| 2007 | 182.62 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 75.53 Million CNY | 472.26% |
| 2024 Q3 | 62.75 Million CNY | -32.29% |
| 2024 Q2 | 92.68 Million CNY | 22.71% |
| 2023 Q3 | 81.37 Million CNY | -7.27% |
| 2023 Q4 | 13.19 Million CNY | -83.78% |
| 2023 Q1 | 97.59 Million CNY | 41.36% |
| 2023 FY | 250.06 Million CNY | -46.6% |
| 2023 Q2 | 87.75 Million CNY | -10.09% |
| 2022 FY | 468.31 Million CNY | -22.19% |
| 2022 Q1 | 121.39 Million CNY | 37.55% |
| 2022 Q4 | 69.04 Million CNY | -51.82% |
| 2022 Q3 | 143.3 Million CNY | 6.49% |
| 2022 Q2 | 134.56 Million CNY | 10.85% |
| 2021 Q3 | 90.44 Million CNY | -3.1% |
| 2021 FY | 601.87 Million CNY | 1.86% |
| 2021 Q2 | 93.34 Million CNY | 14.07% |
| 2021 Q1 | 81.82 Million CNY | 12.69% |
| 2021 Q4 | 88.25 Million CNY | -2.42% |
| 2020 Q2 | 84.68 Million CNY | 66.11% |
| 2020 Q4 | 72.61 Million CNY | -33.57% |
| 2020 FY | 590.9 Million CNY | -10.44% |
| 2020 Q1 | 50.98 Million CNY | -36.52% |
| 2020 Q3 | 109.31 Million CNY | 29.08% |
| 2019 FY | 659.8 Million CNY | 101.38% |
| 2019 Q3 | 84.32 Million CNY | -25.11% |
| 2019 Q1 | 98.73 Million CNY | 46.41% |
| 2019 Q4 | 80.3 Million CNY | -4.76% |
| 2019 Q2 | 112.59 Million CNY | 14.03% |
| 2018 FY | 327.63 Million CNY | 24.27% |
| 2018 Q3 | 74.79 Million CNY | -23.38% |
| 2018 Q1 | 87.78 Million CNY | 38.74% |
| 2018 Q2 | 97.61 Million CNY | 11.2% |
| 2018 Q4 | 67.44 Million CNY | -9.83% |
| 2017 Q4 | 63.27 Million CNY | 9.93% |
| 2017 Q2 | 71.75 Million CNY | 0.98% |
| 2017 FY | 263.64 Million CNY | 18.17% |
| 2017 Q1 | 71.06 Million CNY | 34.2% |
| 2017 Q3 | 57.55 Million CNY | -19.79% |
| 2016 FY | 223.09 Million CNY | 28.98% |
| 2016 Q4 | 52.94 Million CNY | -2.24% |
| 2016 Q1 | 54.46 Million CNY | 32.52% |
| 2016 Q2 | 61.52 Million CNY | 12.96% |
| 2016 Q3 | 54.16 Million CNY | -11.97% |
| 2015 Q3 | 42.13 Million CNY | -18.58% |
| 2015 Q1 | 37.98 Million CNY | 10.27% |
| 2015 Q2 | 51.75 Million CNY | 36.25% |
| 2015 FY | 172.97 Million CNY | -24.15% |
| 2015 Q4 | 41.09 Million CNY | -2.46% |
| 2014 Q2 | 36.01 Million CNY | -71.0% |
| 2014 FY | 228.06 Million CNY | 75.2% |
| 2014 Q4 | 34.44 Million CNY | 3.21% |
| 2014 Q3 | 33.37 Million CNY | -7.33% |
| 2014 Q1 | 124.21 Million CNY | 151.23% |
| 2013 Q2 | 41.76 Million CNY | 130.99% |
| 2013 Q3 | 20.88 Million CNY | -49.99% |
| 2013 Q1 | 18.07 Million CNY | 117.15% |
| 2013 Q4 | 49.44 Million CNY | 136.74% |
| 2013 FY | 130.16 Million CNY | 99.62% |
| 2012 Q4 | 8.32 Million CNY | -50.35% |
| 2012 FY | 65.2 Million CNY | 2.4% |
| 2012 Q2 | 25.8 Million CNY | 80.37% |
| 2012 Q3 | 16.76 Million CNY | -35.03% |
| 2012 Q1 | 14.3 Million CNY | -26.7% |
| 2011 Q3 | 14 Million CNY | -32.67% |
| 2011 Q1 | 9.34 Million CNY | -23.93% |
| 2011 Q2 | 20.8 Million CNY | 122.61% |
| 2011 Q4 | 19.52 Million CNY | 39.35% |
| 2011 FY | 63.68 Million CNY | 31.19% |
| 2010 Q2 | 19.16 Million CNY | 204.58% |
| 2010 Q4 | 12.28 Million CNY | 13.75% |
| 2010 Q3 | 10.8 Million CNY | -43.64% |
| 2010 FY | 48.54 Million CNY | 14.44% |
| 2010 Q1 | 6.29 Million CNY | -35.32% |
| 2009 Q3 | 17.16 Million CNY | 0.0% |
| 2009 Q4 | 9.72 Million CNY | -43.34% |
| 2009 FY | 42.41 Million CNY | 2.57% |
| 2008 FY | 41.35 Million CNY | -77.35% |
| 2007 FY | 182.62 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Yixintang Pharmaceutical Group Co., Ltd. | 549.44 Million CNY | 54.488% |
| ZJAMP Group Co., Ltd. | 380.94 Million CNY | 34.358% |
| Luyan Pharma Co.,Ltd. | 363.53 Million CNY | 31.213% |
| Ji Yao Holding Group Co., Ltd. | -349.3 Million CNY | 171.587% |